Research ArticleArticle
The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis
Milla Johanna Kviatkovsky, Sofia Ramiro, Robert Landewé, Maxime Dougados, Florence Tubach, Nicholas Bellamy, Marc Hochberg, Philippe Ravaud, Emilio Martin-Mola, Hassane Awada, Claire Bombardier, David Felson, Najia Hajjaj-Hassouni, Isabelle Logeart, Marco Matucci-Cerinic, Mart van de Laar and Désirée van der Heijde
The Journal of Rheumatology September 2016, 43 (9) 1680-1686; DOI: https://doi.org/10.3899/jrheum.151244
Milla Johanna Kviatkovsky
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede,
the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris,
France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris,
France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane,
Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts,
USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid,
Spain; Hotel-Dieu de
France Hospital, Saint Joseph University, Rheumatology Department, Beirut,
Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario,
Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé,
Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence,
Italy.
Sofia Ramiro
Robert Landewé
Maxime Dougados
Florence Tubach
Nicholas Bellamy
Marc Hochberg
Philippe Ravaud
Emilio Martin-Mola
Hassane Awada
Claire Bombardier
David Felson
Najia Hajjaj-Hassouni
Isabelle Logeart
Marco Matucci-Cerinic
Mart van de Laar
Désirée van der Heijde
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 43, Issue 9
1 Sep 2016
The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis
Milla Johanna Kviatkovsky, Sofia Ramiro, Robert Landewé, Maxime Dougados, Florence Tubach, Nicholas Bellamy, Marc Hochberg, Philippe Ravaud, Emilio Martin-Mola, Hassane Awada, Claire Bombardier, David Felson, Najia Hajjaj-Hassouni, Isabelle Logeart, Marco Matucci-Cerinic, Mart van de Laar, Désirée van der Heijde
The Journal of Rheumatology Sep 2016, 43 (9) 1680-1686; DOI: 10.3899/jrheum.151244
The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis
Milla Johanna Kviatkovsky, Sofia Ramiro, Robert Landewé, Maxime Dougados, Florence Tubach, Nicholas Bellamy, Marc Hochberg, Philippe Ravaud, Emilio Martin-Mola, Hassane Awada, Claire Bombardier, David Felson, Najia Hajjaj-Hassouni, Isabelle Logeart, Marco Matucci-Cerinic, Mart van de Laar, Désirée van der Heijde
The Journal of Rheumatology Sep 2016, 43 (9) 1680-1686; DOI: 10.3899/jrheum.151244